Skip to content

Evaluation of the Adhesion to the GENEPY Network

Evaluation of the Adhesion to the Network of Care of People at Genetic Risk of Cancer in Midi-Pyrénées (GENEPY)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03979612
Acronym
GENEPY
Enrollment
450
Registered
2019-06-07
Start date
2019-08-01
Completion date
2020-12-31
Last updated
2019-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Breast and Ovarian Cancer, Hereditary Cancer Syndrome, Hereditary Colorectal Endometrial Cancer Syndrome

Keywords

breast, hereditary, cancer, ovarian, predisposition

Brief summary

In order to best meet the needs of all those affected by the genetic risk of cancer in our region, it is important to identify the factors likely to influence the course leading to the GENEPY surveillance network. The aim of this study is to evaluatie the adhesion to the network of care of people at genetic risk of cancer in Midi-Pyrénées (GENEPY).

Detailed description

This network has been open since November 2015 for people who are genetically predisposed to breast / ovarian cancer. The extension to digestive pathologies (HNPCC syndrome, PAF) is in progress. It concerns not only the persons carrying a mutation also those belonging to a family without identified mutation but whose risk of predisposition is important. The GENEPY network is based on a collaboration between oncogenetic consultations in the region and professionals practicing in institutions (private, public) and liberal: general practitioners, gynecologists, radiologists, oncologists, gastroenterologists, psychologists ... It is therefore a multicentric and multidisciplinary network, which aims to promote the local care of people genetically predisposed (or considered at high risk of genetic predisposition), while ensuring a high level of competence, to guarantee an optimal and equitable care on the whole of Midi Pyrenees. The diagnosis of a new genetic disease in an individual is likely to have implications for other family members who may themselves be at risk of developing the disease and / or passing it on to their children. The inclusion of subjects in the GENEPY network follows the genealogical study of a case (index) : relatives are identified as potentially at risk. In accordance with the recommendations, but also generally at the wish of the patients, the index case is then asked to inform its relatives and to propose them to go to an oncogenetic consultation of their choice. If these people reside in the Midi Pyrenees Toulouse oncogenetic consultation is open to them. If following this consultation a mutation is identified or that their genetic risk is considered important, they are proposed to join the GENEPY network for their monitoring.

Interventions

GENETICinclusion of subjects in the GENEPY network

The inclusion of subjects in the GENEPY network follows the genealogical study of a case (index): relatives are identified as potentially at risk. In accordance with the recommendations, but also generally at the wish of the patients (Claes 2003), the index case is then asked to inform its relatives and to propose them to go to an oncogenetic consultation of their choice. If these people reside in the Midi Pyrenees Toulouse oncogenetic consultation is open to them. If following this consultation a mutation is identified or that their genetic risk is considered important, they are proposed to join the GENEPY network for their monitoring.

Sponsors

Institut Claudius Regaud
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* people with an identified mutation, predisposing to tumors of the breast / ovary or colon / rectum * people resident in the Midi-Pyrénées region

Exclusion criteria

* people under 18

Design outcomes

Primary

MeasureTime frameDescription
Cancer status Communication1 dayPatient's agreement to communicate about his illness to his relative
Place of residence of the relatives1 daydistance from the offer of care and level of deprivation (for the relative of the patient who answered the questionnaire)
Proximity to the index case1 dayrelationship of the relatives with the index case according to the latter contact
Adhesion to the GENEPY network6 monthsNetwork membership rate : comparison between the number of relatives who received the invitation and the number of them who joined the network.
Age of relatives1 dayAge of the relative of the patient who answered the questionnaire
Sex of relatives1 daysex of the relative of the patient who answered the questionnaire

Secondary

MeasureTime frameDescription
Practionners satisfaction1 yearsatisfaction of general practitioners (scale of values by questionnaire)
People satisfaction1 yearsatisfaction of people who have joined the network (scale of values by questionnaire)

Countries

France

Contacts

Primary ContactEdith Chipoulet, Msc
chipoulet.edith@iuct-oncopole.fr0531156009
Backup ContactAnne-Laure Fize, MSc
fize.annelaure@iuct-oncopole.fr0531155059

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026